Clinical Trials Directory

Trials / Completed

CompletedNCT01075932

Effects of Docosahexaenoic Acid (DHA)-Rich Fish Oil on Cerebral Haemodynamics

The Cognitive And Cerebral Hemodynamic Effects Of DHA-Rich Fish Oil: A Dose-Ranging Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
65 (actual)
Sponsor
Northumbria University · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

DHA has previously been shown to increase regional cerebral blood flow response to tactile stimulation in aged monkeys; modulation of cerebral blood flow in humans has yet to be demonstrated. Given that the brain relies on a constant supply of blood-borne metabolic substrates (e.g. glucose, oxygen), increasing regional cerebral blood flow may also have an impact on cognitive function. The current study aims to investigate the effects of two doses of DHA-rich fish oil on task-related cerebral hemodynamic response and cognitive performance in healthy adults.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTDHA-rich fish oilEither 1 g or 2 g DHA-rich fish oil taken daily for 12 weeks. Participants in the 1 g group will also consume 1 g olive oil placebo capsules per day to maintain double blind.
DIETARY_SUPPLEMENTPlacebo2 g placebo (olive oil) taken daily for 12 weeks

Timeline

Start date
2009-04-01
Primary completion
2009-05-01
Completion
2009-08-01
First posted
2010-02-25
Last updated
2010-02-25

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01075932. Inclusion in this directory is not an endorsement.

Effects of Docosahexaenoic Acid (DHA)-Rich Fish Oil on Cerebral Haemodynamics (NCT01075932) · Clinical Trials Directory